PubMed:23528904 / 77-157 JSONTXT

{"project":"sentences","denotations":[{"id":"TextSentencer_T2","span":{"begin":0,"end":80},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":80},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"MYCN amplification in neuroblastoma is usually associated with a poor prognosis."}

{"project":"DisGeNET","denotations":[{"id":"T6","span":{"begin":0,"end":4},"obj":"gene:4613"},{"id":"T7","span":{"begin":22,"end":35},"obj":"disease:C0700095"},{"id":"T8","span":{"begin":0,"end":4},"obj":"gene:4613"},{"id":"T9","span":{"begin":22,"end":35},"obj":"disease:C0027819"}],"relations":[{"id":"R4","pred":"associated_with","subj":"T6","obj":"T7"},{"id":"R5","pred":"associated_with","subj":"T8","obj":"T9"}],"namespaces":[{"prefix":"gene","uri":"http://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"disease","uri":"http://purl.bioontology.org/ontology/MEDLINEPLUS/"}],"text":"MYCN amplification in neuroblastoma is usually associated with a poor prognosis."}

{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":22,"end":35},"obj":"HP_0003006"}],"text":"MYCN amplification in neuroblastoma is usually associated with a poor prognosis."}

{"project":"PubCasesHPO","denotations":[{"id":"AB1","span":{"begin":22,"end":35},"obj":"HP:0003006"}],"text":"MYCN amplification in neuroblastoma is usually associated with a poor prognosis."}

{"project":"PubCasesORDO","denotations":[{"id":"AB1","span":{"begin":22,"end":35},"obj":"ORDO:635"}],"namespaces":[{"prefix":"ORDO","uri":"http://www.orpha.net/ORDO/Orphanet_"}],"text":"MYCN amplification in neuroblastoma is usually associated with a poor prognosis."}